POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Nevada Bill Prohibits Health Plans from Requiring Step Therapy for HIV and Hepatitis C Drugs

Original title: AN ACT relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto.

Last action · June 3, 2025: (No further action taken.)Sponsors: Jeff Stone and 3 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

Senate Bill 354 prohibits certain public and private health insurance plans, including Medicaid, from requiring before covering FDA-approved prescription drugs that prevent the acquisition of HIV or treat HIV and hepatitis C. The measure takes full effect on January 1, 2026.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

health insurance policyholders

Policyholders gain guaranteed coverage without step therapy for FDA-approved prescription drugs that prevent HIV acquisition or treat HIV and hepatitis C.

Directly affected

Medicaid recipients

Medicaid recipients are exempted from step therapy protocols when prescribed drugs used to prevent HIV acquisition or treat HIV or hepatitis C.

Directly affected

health insurers

Health insurers and carriers are prohibited from applying step therapy or medical management techniques to specified HIV and hepatitis C prescription drug benefits.

Directly affected

pharmacists

Participating pharmacists providing specified services must be reimbursed at a rate equal to that provided to physicians, physician assistants, or advanced practice registered nurses.

Key Facts

  • Insurers offering health insurance, group health insurance, health benefit plans, benefit contracts, hospital or medical services policies, health maintenance organization plans, and managed care plans must cover all FDA-approved drugs for preventing HIV acquisition or treating HIV or hepatitis C without regard to formulary status.
  • Health plans are prohibited from subjecting required HIV and hepatitis C drug benefits to medical management techniques such as step therapy.
  • Insurers are prohibited from limiting the covered amount of these specified prescription drugs.
  • Insurers cannot refuse to cover these drugs because they are dispensed through a mail order service.
Show all 9 facts
  • Insurers cannot prohibit or restrict access to any service or drug to treat HIV or hepatitis C on the same day the insured is diagnosed.
  • Policies delivered, issued for delivery, or renewed on or after January 1, 2026, automatically include these coverage requirements, and conflicting provisions are void.
  • The Medicaid program and other specified health plans are prohibited from applying step therapy protocols to drugs used to prevent HIV acquisition or treat HIV or hepatitis C.
  • Pharmacists participating in a network plan must be reimbursed for specified services at a rate equal to the rate provided to a physician, physician assistant, or advanced practice registered nurse.
  • Local government additional expenses related to the act are exempted from the limitations of NRS 354.599.

Frequently Asked Questions

What health insurance plans are affected by this bill?
The bill affects various public and private health plans in Nevada, including individual and group health insurance policies, health benefit plans, benefit contracts, hospital or medical services corporation policies, health maintenance organization plans, managed care plans, and Medicaid.
Can insurers refuse to cover HIV or hepatitis C drugs if obtained via mail order?
No. Insurers are explicitly prohibited from refusing to cover these prescription drugs simply because they are dispensed by a pharmacy through a mail order service.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in Senate committee.

Procedural history

6 actions
  1. Jun 3, 2025
    (No further action taken.)
  2. Apr 25, 2025Committee
    From printer. To engrossment. Engrossed. First reprint. To committee.
  3. Apr 22, 2025Committee
    Notice of eligibility for exemption. Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.
  4. Apr 21, 2025
    From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 315.) Reprinting dispensed with.
  5. Mar 17, 2025Committee
    From printer. To committee.
  6. Mar 13, 2025Introduced
    Read first time. Referred to Committee on Commerce and Labor. To printer.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift98% confidence

Elimination of Step Therapy for Critical Infectious Disease Medications

The legislation systematically removes step therapy exemptions across multiple chapters of Nevada law governing different types of health plans, Medicaid, and managed care organizations.

Connected Entities

Melanie Scheible, Drug Use Review Board, State Board of Nursing and 4 more
PersonMelanie Scheible“Nevada State Senator and co-sponsor”Map →
OrganizationDrug Use Review Board“Advises the Department concerning Medicaid prescription drug use”Map →
OrganizationState Board of Nursing“Prescribes training and experience for advanced practice registered nurses”Map →
PersonJeff Stone“Nevada State Senator sponsoring SB 354”Map →
OrganizationUnited States Food and Drug Administration“Federal agency approving prescription drugs”Map →
PersonJames Ohrenschall“Nevada State Senator and co-sponsor”Map →
PersonRebecca Edgeworth“Assemblymember and joint sponsor”Map →

Sources

Open source document

www.leg.state.nv.us

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 75)
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record